Introduction
Endovascular platinum coil embolization has revolutionized the treatment of intracranial aneurysms, but post-coiling recurrence remains a problem, leading to longterm angiographic surveillance and re-treatments when aneurysms recur. [1] [2] [3] A multicenter registry has reported up to 15% re-treatment rates at 2 years after coiling of ruptured aneurysms, but a yearly re-rupture rate of only 0.2% after the first year. 4 Recurrence has been linked to several factors, including rupture status, aneurysm size, neck width, degree of obliteration at initial treatment, and initial packing density. 5, 6 Second-generation coils have been designed, but clinical trials have not been convincing, except perhaps for small aneurysms (2-9.9 mm) more likely to have an improved angiographic outcome when treated with hydrogel-coated coils in a subgroup analysis, an improvement inferred to result from higher packing density afforded by hydrogel expansion. [7] [8] [9] [10] [11] We hypothesized that similar results could be achieved by using more voluminous bare platinum coils. Large-caliber platinum coiling systems (15caliber coils) have recently been introduced to more completely fill small aneurysms with embolic material. 12 We sought to determine the potential for these largercaliber coils to achieve higher packing densities in aneurysms of 4-12 mm and ultimately decrease recurrence rates at 1 year. The Does Embolization with Larger coils lead to better Treatment of Aneurysms (DELTA) trial was initiated to examine the safety and efficacy of endovascular coil embolization with 15-caliber coils (Deltamaxx Microcoil; Codman Neuro DePuy Synthes, Raynham, MA, USA) compared with embolization with 10-caliber coils. We report here preliminary results from the pilot phase on the capacity to improve packing density (DELTA trial NCT01943591).
Methods

Trial design
DELTA is an investigator-initiated multicenter prospective, randomized, controlled, single-blind clinical trial. The study is registered and summarized on https://clinicaltrials.gov/NCT01943591, and the full protocol can be found at http://www.clinical-caretrials.org/. The trial's inclusion criteria are wide: adult patients with at least two years of life expectancy, harboring a ruptured (World Federation of Neurosurgical Societies (WFNS) grade I-III subarachnoid hemorrhage (SAH)) or unruptured 4-12-mm intracranial aneurysm, considered for endovascular coil embolization and amenable for treatment with either 15-caliber or 10-caliber coils. The exclusion criteria are few: patients with planned treatment of an associated cerebral arteriovenous malformation and those in whom parent vessel occlusion is the primary intent of the procedure. Patients are randomized on a web-based platform in a 1:1 ratio to treatment with either 15caliber coils (intervention arm) or 10-caliber coils (standard treatment arm), using rupture status and previous treatment as minimization criteria. According to the study protocol, patients allocated to the 15-caliber coiling group are preferably to receive as many 15-caliber coils as safely achievable, but the procedure can be completed with 10-caliber filling or finishing coils in order to optimize complete occlusion. Patients allocated to the 10-caliber coiling group will only receive coils of the latter size. Operators have the technical freedom to use any adjunctive technique. The study does not require any additional testing or procedure other than routine practice at the participating center. The primary efficacy endpoint of DELTA is the occurrence of a major recurrence or a residual aneurysm at the time of follow-up angiography at 12 AE 2 months. Secondary outcomes include indices of immediate treatment success as well as standard safety outcomes. The study was powered to detect a decrease in recurrence rate from 33% to 20% with an alpha error of 5%, a beta error of 10% and a sample size of 564 patients.
The trial was sponsored by the Centre Hospitalier de l'Universite´de Montre´al and funded by Johnson & Johnson Medical products, a division of Johnson & Johnson Inc. and DePuy Synthes. The sponsor and funder have no role in study design, data collection, analysis, or reporting and have no direct or indirect access to the data or source documents. The Steering Committee bears the sole responsibility for all aspects of the trial.
The study rolled out as a pilot phase examining the safety and feasibility of the coiling strategy, compliance to treatment group allocation, recruitment rates, and the capacity to improve packing density. The primary hypothesis of the pilot phase was an increase in packing density from 25% in the control group to 28% in the intervention group with a 95% power and a two-sided alpha error of 0.05, hence requiring the recruitment of 165 patients. Increase in packing density was the only primary endpoint of the pilot phase, since a rather small sample size was required to determine effect size and ultimately allow the study to proceed into the pivotal stage with the primary hypothesis of achieving a clinically relevant result (lower rate of recurrence).
Packing density or volume embolization ratio (VER) is the volume of inserted coils divided by the aneurysm volume. Coil volume was calculated using the formula (V ¼ (p(c/2)2L)) where c is coil caliber and L is coil length for coils entered in the procedural case report forms (CRFs). Aneurysm volumes were determined using a simple mathematical model (V ¼ 4/3 p ab 2 , where a and b are half the long and short axes of the aneurysm, as entered on the CRFs).
Immediate angiographic outcomes were the values entered in the CRFs (complete occlusion, residual neck and residual aneurysm self-adjudicated by operators). For the pivotal trial analysis, adjudication is planned through a blinded core laboratory. The following secondary outcomes were also collected for this report: total number of coils used per aneurysm, total fluoroscopy time (the addition of the time, in minutes, for both detectors of the bi-plane angiography unit) and any adverse or undesirable event.
The Mann-Whitney U test was used for non-parametric comparisons and the Pearson Chi-square test for frequency comparison.
Results
Between June 2014 and November 2015, 70 patients were recruited. Thirty-three patients were allocated to the 15-caliber group vs. 37 to the 10-caliber group. The baseline patients' and aneurysms' characteristics were similar (Table 1) . One cross-over occurred when a patient allocated to the 10-caliber group received a 15-caliber coil due to an operator error.
Results are summarized in Table 2 . The median packing density of aneurysms treated with the 15-caliber coils was significantly higher (41% vs. 23%, p ¼ 0.017). Other secondary outcomes were similar, namely, the total number of coils per aneurysm, the mean fluoroscopy time, initial angiographic outcomes and adverse events. Given the small sample number and rare events in the comparison groups, no p values are reported for the collected secondary outcomes in this brief report.
Discussion
Preliminary results from the pilot phase of a randomized trial have shown the feasibility of using a 15caliber coiling system for the treatment of most small aneurysms. This strategy can significantly increase the packing density of treated aneurysms. Immediate angiographic results and procedural complications were similar. Finally, recruitment occurred at a rate of 4.8 patients per month.
Packing density has been conceived as an estimate of the extent to which an aneurysm is filled with embolic coiling material. [13] [14] [15] It has been thought to play a role in estimating with 'objectivity' the success of the initial endovascular treatment, at least as compared with other, more subjective endpoints, such as angiographic results. 16 Inferior packing density has been associated with an increased risk of angiographic recurrences in some observational follow-up angiographic studies, [17] [18] [19] but randomized evidence is not available. A retrospective comparison between 32 matched pairs of patients extracted from a data base of over 1000 coiled aneurysms has previously shown that coiling with caliber 18 coils led to increased packing density as compared with caliber 10 coils. 20 Our study differs by being a prospective randomized trial.
Even though packing density can be calculated with relative ease, its value in predicting inferior follow-up angiographic results remains controversial. 21, 22 Packing density is not independent of other risk factors for recurrences, such as large aneurysms, wide-necked aneurysms, and aneurysms that are incompletely occluded after the initial treatment. 5, 6, 18, 19, 23 Packing density is not an end in itself, but it was used as an endpoint of the pilot phase, because it was thought that if the use of larger-caliber coils could not impact packing density, it would be unlikely to change the treatment significantly enough to impact long-term angiographic results.
Whether the increased packing density obtained with larger-caliber coils will translate into better 1-year angiographic results is a question that can only be answered by completing the pivotal phase of the trial.
Our study has several limitations. The method that was used to calculate aneurysm volumes is not as accurate as more exact experimental methods. 6, 24 Although most systems include software that makes volume measurements on 3D angiograms readily accessible, this is not routinely performed in all centers and was not required by the pragmatic design of the protocol. The method we used is simple and commonly used for clinical purposes; it is immediately available from the data collected on the CRFs. Similar methods have been used in many published trials. 11 This method likely results in overestimating aneurysm volumes and underestimating packing densities, but it is unlikely to introduce bias in the comparison because of random allocation, as measurement errors are expected to be the same for both groups. The number of patients is small, and 1-year angiographic results remain to be obtained and adjudicated by the core laboratory.
Conclusion
Coiling of aneurysms randomized to 15-caliber coils achieved higher packing densities compared with coiling using 10-caliber coils.
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